West Pharmaceutical Services, Inc. (WST)

Price$316.30

Value ScoreD

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)9.30%

Price vs S&P 500 (4W)2.39%

VGM Score53.82

Market Capitalization$22.81B

P/E Ratio (Annual)46.19x

Indicated Dividend Yield (Annual)0.33%

All Metrics

P/CF (Annual)30.21x

Book Value / Share (Quarterly)$42.18

P/TBV (Annual)6.25x

Indicated Dividend (Annual)$0.88

Revenue Growth (3Y)2.12%

Cash Flow / Share (Quarterly)$6.46

Payout Ratio (TTM)11.39%

Price vs S&P 500 (YTD)6.39%

Gross Margin (TTM)36.28%

Net Profit Margin (TTM)16.85%

EPS (TTM)$7.48

10-Day Avg Trading Volume0.69M

EPS Excl Extra (TTM)$7.48

Revenue Growth (5Y)7.44%

EPS (Annual)$6.79

Dividend / Share (Annual)$0.85

ROI (Annual)14.59%

Gross Margin (Annual)35.91%

Net Profit Margin (5Y Avg)19.38%

Cash / Share (Quarterly)$7.35

P/E Basic Excl Extra (TTM)42.02x

Revenue Growth QoQ (YoY)21.05%

EPS Growth (5Y)8.26%

P/E Normalized (Annual)46.19x

ROA (Last FY)11.56%

Revenue Growth TTM (YoY)11.23%

EBITD / Share (TTM)$11.43

ROE (5Y Avg)20.93%

Operating Margin (TTM)20.34%

Cash Flow / Share (Annual)$6.51

P/B Ratio7.63x

P/B Ratio (Quarterly)5.94x

Net Income / Employee (Annual)$45,700

EV / Revenue (TTM)6.98x

Net Interest Coverage (TTM)130.12x

ROA (TTM)13.21%

EPS Growth QoQ (YoY)55.85%

EV / EBITDA (TTM)27.13x

EPS Incl Extra (Annual)$6.79

Current Ratio (Annual)3.02x

Quick Ratio (Quarterly)2.04x

3-Month Avg Trading Volume0.96M

52-Week Price Return53.38%

EV / Free Cash Flow (Annual)47.97x

P/E Incl Extra (TTM)42.02x

Revenue / Employee (TTM)$298,200

Tangible BV / Share (Quarterly)$42.08

P/S Ratio (Annual)7.42x

Asset Turnover (Annual)0.72x

52-Week High$330.88

Operating Margin (5Y Avg)22.38%

EPS Excl Extra (Annual)$6.79

CapEx CAGR (5Y)10.39%

Tangible BV CAGR (5Y)11.68%

26-Week Price Return25.23%

Quick Ratio (Annual)2.34x

13-Week Price Return29.63%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)2.71x

Enterprise Value$22.49B

Revenue / Share Growth (5Y)8.34%

Asset Turnover (TTM)0.78x

Book Value / Share Growth (5Y)11.97%

Revenue / Employee (Annual)$284,600

Inventory Turnover (Annual)4.80x

Pretax Margin (Annual)19.55%

Cash / Share (Annual)$10.99

3-Month Return Std Dev37.48%

Gross Margin (5Y Avg)37.93%

Net Income / Employee (TTM)$50,300

EBITDA CAGR (5Y)2.72%

EBITDA Interim CAGR (5Y)1.77%

ROE (Last FY)15.54%

Net Interest Coverage (Annual)128.54x

EPS Basic Excl Extra (Annual)$6.79

P/FCF (TTM)49.79x

Receivables Turnover (TTM)5.07x

EV / Free Cash Flow (TTM)49.11x

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$7.48

Receivables Turnover (Annual)5.29x

ROI (TTM)16.73%

Dividend Growth Rate (5Y)5.48%

P/S Ratio (TTM)7.08x

Pretax Margin (5Y Avg)22.69%

Revenue / Share (Annual)$42.28

Tangible BV / Share (Annual)$44.00

Forward P/E35.95x

Free OCF CAGR (5Y)9.48%

Price vs S&P 500 (52W)25.18%

P/E Ratio (TTM)42.02x

EPS Growth TTM (YoY)17.51%

Year-to-Date Return17.33%

5-Day Price Return2.02%

EPS Normalized (Annual)$6.79

ROA (5Y Avg)15.35%

Net Profit Margin (Annual)16.06%

Month-to-Date Return8.47%

Cash Flow / Share (TTM)$8.90

EBITD / Share (Annual)$8.05

EPS Growth (3Y)-4.22%

Operating Margin (Annual)19.03%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)31.88x

ROI (5Y Avg)19.34%

P/E Excl Extra (TTM)42.02x

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$7.48

P/TBV (Quarterly)5.96x

Payout Ratio (Annual)12.40%

P/B Ratio (Annual)6.23x

Dividend / Share (TTM)$0.87

Inventory Turnover (TTM)4.88x

Pretax Margin (TTM)20.82%

Book Value / Share (Annual)$44.11

Price vs S&P 500 (13W)19.89%

Net Margin Growth (5Y)-0.09%

Dividend Yield (TTM)0.27%

Beta1.18x

P/FCF (Annual)48.64x

Revenue / Share (TTM)$44.49

ROE (TTM)17.87%

52-Week Low$206.10

vGradeD

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 262.13est. 1.69

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.04

4.09

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95
GMEDGLOBUS MEDICAL INC	B	A	C	$79.78

About

West Pharmaceutical Services supplies critical packaging and delivery systems to the pharmaceutical, biotechnology, and generic drug industries. Its products include elastomer-based packaging components, nonglass containment solutions, and auto-injectors for biologics, GLP-1 agonists, and small-molecule drugs. The company derives approximately 80% of revenue from proprietary products and 20% from contract manufacturing, with 55% of revenue from international markets.